Bern Daily Press
SEE OTHER BRANDS

Your daily news update on Switzerland

Bern Daily Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bern Daily Press.

Press releases published on August 19, 2025

Seven-Member Jury for Karger’s Sixth Annual Vesalius Innovation Award Set

Seven-Member Jury for Karger’s Sixth Annual Vesalius Innovation Award Set

Early-stage startups in health sciences …

USIA présente Red Art Project, une exposition commissariée par Francisco Lacerda

USIA présente Red Art Project, une exposition commissariée par Francisco Lacerda

USIA présente RED ART PROJECT : des artistes internationaux réinventent la puissance du rouge dans une exposition commissariée par Francisco Lacerda GENèVE , SWITZERLAND, August 19, 2025 /⁨EINPresswire.com⁩/ -- USIA (United State of International Artists …

Crown Point Capital Rolls Out Global Investor Protection Program This Quarter

Crown Point Capital Rolls Out Global Investor Protection Program This Quarter

Zurich, Switzerland, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Crown Point Capital has officially announced the launch of its Global Investor Protection Program, set to roll out this quarter. As part of the company’s continuing evolution as a premier crypto …

TRYVIO™ (aprocitentan) now included in ACC/AHA Clinical Practice Guidelines for the treatment of hypertension

TRYVIO™ (aprocitentan) now included in ACC/AHA Clinical Practice Guidelines for the treatment of hypertension

The updated recommendations now include TRYVIO™ (aprocitentan) – the first and only hypertension treatment targeting the endothelin pathway. Endothelin is upregulated in hypertension and is a fundamental mediator in patients whose hypertension is difficult …

Memo Therapeutics AG Publishes Phase I Safety, Tolerability, and Pharmacokinetics Study for Neutralizing Antibody Targeting BKPyV Infection in Clinical and Translational Science

Memo Therapeutics AG Publishes Phase I Safety, Tolerability, and Pharmacokinetics Study for Neutralizing Antibody Targeting BKPyV Infection in Clinical and Translational Science

First-in-human, Phase I, randomized, placebo-controlled study, successfully demonstrated safety and tolerability of potravitug in healthy volunteers The Company recently announced the results from its Phase II placebo-controlled clinical trial of …

Sportradar Strengthens Bundesliga International Relationship With Launch of Innovative New Products Starting 2025-26 Season

Sportradar Strengthens Bundesliga International Relationship With Launch of Innovative New Products Starting 2025-26 Season

ST. GALLEN, Switzerland and FRANKFURT, Germany, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Bundesliga International is strengthening its longstanding agreement with Sportradar Group AG (NASDAQ: SRAD) to further enhance the viewing experience, accelerate innovation …

Basilea mit starkem Halbjahresergebnis 2025 auf Kurs

Basilea mit starkem Halbjahresergebnis 2025 auf Kurs

Cresemba- und Zevtera-basierte Umsätze steigen um 24 % auf CHF 90.5 Mio. Gesamtumsatz steigt signifikant um 36 % auf CHF 104.0 Mio. Betriebsgewinn springt um 160 % auf CHF 24.0 Mio. Operativer Cashflow erhöht sich um 29 % auf CHF 23.1 Mio. Guidance für das …

Basilea on track with strong 2025 half-year results

Basilea on track with strong 2025 half-year results

Cresemba® and Zevtera®-related revenues rise by 24% to CHF 90.5 million Total revenue grows significantly by 36% to CHF 104.0 million Operating profit surges by 160% to CHF 24.0 million Operating cash flow increases by 29% to CHF 23.1 million Full-year …

Santhera schließt Vereinbarung mit Uniphar über den Vertrieb von AGAMREE® (Vamorolon) in fünf Ländern des Golf-Kooperationsrats (GCC)

Santhera schließt Vereinbarung mit Uniphar über den Vertrieb von AGAMREE® (Vamorolon) in fünf Ländern des Golf-Kooperationsrats (GCC)

Pratteln, Schweiz, 19. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Uniphar über den Vertrieb von AGAMREE® (Vamorolon) in den Vereinigten Arabischen Emiraten, Saudi-Arabien, Kuwait, Oman und …

Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries

Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries

Pratteln, Switzerland, 19 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia, Kuwait, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions